You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 7,563,763


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,563,763
Title:FSH and FSH variant formulations, products and methods
Abstract: This invention relates to FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and products of said proteins and nucleic acids where none approved for commercial use had previously existed having such extended use indications. These products are particularly useful in therapeutic regimens for increasing serum levels of FSH or a FSH variant over a period of treatment. Thus, inter alia, the invention fills the need for convenient products of FSH or from a FSH variant.
Inventor(s): Hoffmann; James Arthur (Greenwood, IN), Lu; Jirong (Indianapolis, IN)
Assignee: Ares Trading S.A. (Aubonne, CH)
Application Number:11/212,423
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Patent Landscape: A Comprehensive Analysis of US Patent 7,563,763

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions. The United States Patent and Trademark Office (USPTO) is responsible for granting these rights, but the process is complex and influenced by various factors. This article will delve into the specifics of US Patent 7,563,763, analyzing its claims, the broader patent landscape, and the implications of recent trends and regulations.

The Patent System Overview

Before diving into the specifics of US Patent 7,563,763, it is essential to understand the broader patent system. The USPTO receives millions of patent applications each year, but not all are granted. According to a study, only about 55.8% of patent applications filed between 1996 and 2013 were granted without using continuation procedures[1].

Patent Allowance Rates

The allowance rate for patents has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications." This trend indicates a more stringent examination process, which can affect the likelihood of a patent being granted[1].

Continuation Procedures

Continuation procedures are crucial in the patent application process. These procedures allow applicants to file additional applications related to their original (progenitor) application. There are two types: non-serialized continuations, such as Requests for Continued Examination (RCEs), and serialized continuations. These procedures can significantly impact the outcome of a patent application[1].

US Patent 7,563,763: An Example

To illustrate the complexities of the patent system, let's consider US Patent 7,563,763. While the specific details of this patent are not provided in the sources, we can analyze it within the context of general patent practices.

Claims and Specifications

A patent's claims are its most critical component, defining the scope of the invention. The specifications provide detailed descriptions and drawings that support these claims. For any patent, including US Patent 7,563,763, the claims must be clear, concise, and fully supported by the specifications to withstand scrutiny during the examination process.

Examination Process

The examination process involves a thorough review by a USPTO examiner to ensure the invention is novel, non-obvious, and useful. This process can involve multiple rounds of office actions, where the examiner may reject certain claims or request additional information. The applicant must respond to these actions to address any issues raised.

Technology Fields and Patent Trends

Patents are classified into various technology fields, such as electrical engineering, mechanical engineering, and computer technology. The number of patents in these fields has seen significant growth, especially in areas like information and communication technologies (ICT)[4].

Electrical Engineering and ICT

Electrical engineering patents, which include computer technology and digital communication, have more than doubled between 2000 and 2018. This growth reflects the rapid advancement in these fields and the increasing importance of ICT in modern innovation[4].

Economic and Legal Implications

The value of a patent extends beyond its legal protection; it also has significant economic implications.

Patent Values and Renewal Choices

Research by the USPTO's Office of the Chief Economist has shown that patent values can be estimated based on renewal choices and citation dynamics. Patents with higher forward citations tend to have greater economic value, but this value depreciates over time[3].

FRAND and SEP Regulations

In the context of Standard Essential Patents (SEPs), the European Commission's proposal for SEP regulation has sparked controversy. The proposal includes a non-binding FRAND determination process, which critics argue could unfairly delay court actions and undermine the true value of SEPs. This highlights the complex interplay between patent law and competition law[2].

Critical Analysis of Patent Claims

When analyzing the claims of a patent like US Patent 7,563,763, several factors come into play:

Novelty and Non-Obviousness

The claims must be novel and non-obvious to be granted. This involves a thorough search of prior art to ensure the invention is unique and not an obvious improvement over existing technologies.

Enablement and Written Description

The specifications must enable a person of ordinary skill in the relevant field to make and use the invention. Additionally, the written description must clearly describe the invention and its claims.

Challenges in the Patent Landscape

The patent landscape is fraught with challenges, including the increasing complexity of technology, the rise of continuation procedures, and the evolving regulatory environment.

Continuation Procedures and Their Impact

Continuation procedures can significantly extend the patent application process. While they provide applicants with additional opportunities to secure patent protection, they can also lead to delays and increased costs[1].

Regulatory Changes and Their Effects

Proposals like the European Commission's SEP regulation can have far-reaching effects on patent holders and implementers. These changes must be carefully considered to ensure they do not inadvertently stifle innovation or create unfair advantages[2].

Key Takeaways

  • Patent Allowance Rates: The probability of receiving a US patent has decreased over time, especially in certain technology fields.
  • Continuation Procedures: These procedures are common and can impact the outcome of a patent application.
  • Technology Fields: Patents in fields like electrical engineering and ICT have seen significant growth.
  • Economic Implications: Patents have substantial economic value, which can be estimated through renewal choices and citation dynamics.
  • Regulatory Environment: Changes in regulations, such as those proposed for SEPs, can have significant implications for patent holders and implementers.

FAQs

  1. What is the current patent allowance rate in the US?

    • The overall patent allowance rate is approximately 55.8% without using continuation procedures, though this rate has decreased over time, especially in certain fields[1].
  2. How do continuation procedures affect the patent application process?

    • Continuation procedures allow applicants to file additional applications related to their original application, which can extend the process but also provide additional opportunities for securing patent protection[1].
  3. What are the main criticisms of the European Commission's SEP regulation proposal?

    • Critics argue that the proposal restricts a patentee's court access during the FRAND determination procedure, potentially delaying court actions and undermining the true value of SEPs[2].
  4. How are patent values estimated?

    • Patent values can be estimated based on renewal choices and citation dynamics, with patents having higher forward citations generally having greater economic value[3].
  5. What is the significance of ICT in patent trends?

    • ICT has driven significant growth in electrical engineering patents, reflecting the rapid advancement and increasing importance of these technologies in modern innovation[4].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Kluwer Patent Blog. (2024, February 27). A Critical Analysis of the EC Proposal for SEP Regulation.
  3. USPTO. (2024). Examining U.S. Patent Values: Renewal Choices, Citation Dynamics, and Economic Growth. USPTO Economic Working Paper No. 2024-5.
  4. NSF. (2020, January 15). Invention: U.S. and Comparative Global Trends. National Science Foundation.

More… ↓

⤷  Subscribe

Details for Patent 7,563,763

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Usa Llc, A Subsidiary Of Organon & Co. FOLLISTIM AQ CARTRIDGE follitropin beta Injection 021211 March 23, 2004 ⤷  Subscribe 2018-07-23
Organon Usa Llc, A Subsidiary Of Organon & Co. FOLLISTIM AQ CARTRIDGE follitropin beta Injection 021211 February 11, 2005 ⤷  Subscribe 2018-07-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.